๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Hangzhou 373 Huzhou 16 Ningbo 15 Shanghai 13 Hanzhou 13
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63 Clear sponsor filter
Site location
Hangzhou373 Huzhou16 Ningbo15 Shanghai13 Hanzhou13
All 69 locations
Target enrolment
to

Trials with a site in Hangzhou

373 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
NCT07716176Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
74
Hangzhou
2025-12-12
Recruiting
Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder
NCT07466277Social Anxiety Disorder (SAD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-12-09
Recruiting
A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma
NCT07306299Glioma, High Grade
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
10
Hangzhou
2025-12-01
Recruiting
Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression
NCT07670026Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
31
Hangzhou
2025-12-01
Recruiting
Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia
NCT07263906Refractory Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hangzhou
2025-12-01
Not yet open
Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction
NCT07250152Myocardial Infarction (MI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,544
Hangzhou
2025-12-01
Recruiting
Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence
NCT07252986Breast, Breast Cancer, Pathology
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
2,000
Hangzhou
2025-12-01
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
NCT07537699Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
NCT07537673Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
NCT07537660Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Recruiting
Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
NCT07301853Living Donor Liver Transplantation Recipients, Deceased Donor Liver Transplantation Recipients, Living Liver Donor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
9,999
Hangzhou
2025-11-24
Recruiting
Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
NCT07321756Lens Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
320
Hangzhou
2025-11-17
Not yet open
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
NCT07244666Glioblastoma (GBM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase EARLY_PHASE1
36
Hangzhou
2025-11-15
Active, closed
Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment
NCT07451158Migraine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
206
Hangzhou
2025-11-15
Recruiting
A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps
NCT07244094Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
400
Changchun, Tianjin, Hangzhou
2025-11-15
Recruiting
Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
NCT07244328Epilepsy, MTLE
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase EARLY_PHASE1
6
Hangzhou
2025-11-10
Recruiting
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
NCT07247396Peritoneal Metastases From Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
12
Hangzhou
2025-11-03
Recruiting
Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
NCT07479758Major Depressive Disorder (MDD), Schizophrenia, Bipolar Disorder, Severe Mental Disorders
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
320
Hangzhou
2025-11-01
Recruiting
The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
NCT07617246Esophagus Cancer, Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
120
Hangzhou
2025-11-01
Recruiting
Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning
NCT07417800Hepatocellular Carcinoma (HCC), Artificial Intelligent, Adjuvant Chemoradiotherapy, TACE
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
11,000
Hangzhou
2025-11-01
Recruiting
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07359014Relapse Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
25
Hangzhou
2025-11-01
Recruiting
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
NCT07244640Parkinson's Disease (PD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
200
Hangzhou
2025-11
Recruiting
A Digitally-Enabled System for Precision Assessment and Intervention of Disability Risk in Older Adults
NCT07508813Disability
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
238
Hangzhou
2025-10-31
Active, closed
ClinicAL outComes of IntraVascular Lithotripsy Combined With Conventional Lesion Preparation in Patients With Moderate to Severe Coronary Artery Calcification
NCT07340294Coronary Artery Calcification, Calcific Coronary Arteriosclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,096
Nanchang, Shenyang, Hangzhou, Tianjin
2025-10-24
Active, closed
Fertility Decision and Outcomes in Young Women With Breast Cancer
NCT07804745Breast Cancer - Female, Fertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
300
Changchun, Hangzhou
2025-10-15
Recruiting
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
NCT07447570Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
27
Hangzhou
2025-10-15
Recruiting
A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
NCT07250386NSCLC (Advanced Non-small Cell Lung Cancer), Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hangzhou
2025-10-13
Recruiting
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
NCT07385131Inflammatory Bowel Disease (IBD), CD - Crohn's Disease, UC - Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
300
Hangzhou
2025-10-08
Recruiting
Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma
NCT07354009Glaucoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
60
Hangzhou
2025-10-07
Recruiting
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
NCT07329686Herpes Simplex Keratitis, Corneal Neovascularization
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
100
Hangzhou
2025-10-01
Recruiting
Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury
NCT07263217Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
30
Hangzhou
2025-10-01
Active, closed
A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts
NCT07197541Plantar Wart
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
200
Hangzhou
2025-10-01
Recruiting
Vebreltinib for Advanced or Metastatic CCS
NCT07153887Clear Cell Sarcoma (CCS)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2025-09-30
Recruiting
A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
NCT06465719Basal Ganglia Hemorrhage
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
330
Hangzhou
2025-09-30
Recruiting
RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH
NCT07205263Basal Ganglia Hemorrhage, Intraventricular Hemorrhage, Brainstem Stroke, Intracranial Hemorrhage, Spontaneous
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,000
Hangzhou
2025-09-30
Recruiting
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
NCT07193628Refractory Glioblastoma, Recurrent Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
14
Hangzhou
2025-09-26
Active, closed
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma
NCT07247383Marginal Zone Lymphoma of Ocular Adnexal, Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
39
Hangzhou
2025-09-19
Recruiting
Accelerated Intermittent Theta Burst Stimulation (AiTBS)on Neuropathic Pain
NCT07148388Neuropathic Pain, Nociceptive Pain
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2025-09-12
Recruiting
Microneedle Intra-Arterial Injection for Retinal Artery Occlusion
NCT07151755Central Retinal Artery Occlusion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
24
Hangzhou
2025-09-01
Not yet open
The Resistant Starch Intervention for Cognitive Enhancement
NCT07152483Cognitive Impairment, Diet Interventions, Cognitive Decline, Genetic Risk Factors
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
70
Hangzhou
2025-09-01
Recruiting
AI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256Gliomas, Brain Metastases, Adult, Lymphoma, Brain Tumor Adult
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,000
Hangzhou
2025-09-01
Not yet open
Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome
NCT07079696Dup15q Syndrome, Autism Spectrum Disorder, Therapy, All-trans Retinoic Acid
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
90
Hangzhou
2025-09-01
Recruiting
Clinical Evaluation of With or Without Internal Limiting Membrane Peeling for Idiopathic Epiretinal Membrane Surgery: A Randomized Controlled Trial
NCT07142785Idiopathic Epiretinal Membranes
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
96
Hangzhou
2025-09-01
Recruiting
EUS-PPG Alteration After Ligation and Sclerotherapy in Esophageal Varices
NCT07253090Esophagogastric Varices
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
70
Hangzhou
2025-08-18
Recruiting
A Single-Center Clinical Study on the Efficacy and Safety of VISOR
NCT07071948Urolithiasis, Calcium Oxalate, Kidney Stone
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
20
Hangzhou
2025-08-06
Not yet open
Smartphone Multimodal Health Intervention for Neurological Enhancement (SHINE)
NCT07092371Cognitive Impairment, Dementia, Artificial Intelligence (AI), Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,036
Hangzhou
2025-08-01
Recruiting
A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast Cancer
NCT07304934Breast Cancer, Axillary Lymph Node Metastasis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
400
Hangzhou
2025-08-01
Not yet open
Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion
NCT07114107Atopic Rhinitis, Atopic Asthma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
200
Hangzhou
2025-08
Recruiting
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
NCT07061535Extensive-stage Small Cell Lung Cancer (ES-SCLC), Extensive Stage Lung Small Cell Cancer, Extensive-Stage Small-Cell Lung Cancer, Extensive Disease Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
40
Changsha, Jinan, Hangzhou
2025-07-30
By invitation
Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvรฉ-Perthes Disease
NCT07122323Legg-Calvรฉ-Perthes Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
50
Hangzhou
2025-07-28
Active, closed
Study on the Application of Adaptive Fluidics Technology in Lens Diseases Surgery
NCT07062107Lens Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
320
Hangzhou
2025-07-20
Recruiting
Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy
NCT07276932Postoperative Chemotherapy, Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
106
Hangzhou
2025-07-16
Recruiting
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
NCT07114120Bronchiectasis, COPD
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
214
Hangzhou, Huzhou, Jinhua, Yueqing, Zhoushan
2025-07-14
Recruiting
Epidural Electrical Stimulation in Spinal Cord Injury (T11-L3)
NCT07207798Spinal Cord Injuries (SCI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-07-01
Active, closed
18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
NCT07449858Non Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Guangzhou, Shenyang, Chengdu, Hangzhou
2025-07-01
Active, closed
VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI
NCT07533656In-Stent Restenosis, Coronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,600
Hangzhou
2025-07-01
By invitation
A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies
NCT07114133Cat Allergy (Disorder), Allergic Rhinitis, Allergic Asthma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-06-30
Recruiting
A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC
NCT07193641Non Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-06-15
Recruiting
Leucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
NCT07359989Rectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
33
Hangzhou
2025-06-11
Recruiting
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
NCT07271576Liver Fibrosis, Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-06-04
Recruiting
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
NCT07293325Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
66
Hangzhou
2025-06-02
Recruiting
Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta
NCT07092358Hereditary Ataxia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,000
Hangzhou, Shanghai
2025-06-01
Active, closed
The R-E-V-I-V-A-L Study
NCT06992674Vestibular Migraine
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
240
Hangzhou
2025-06-01
Recruiting
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
NCT06742125ST-elevation Myocardial Infarction (STEMI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,244
Hangzhou
2025-05-31
By invitation
The Efficacy and Safety of IBI351, Cetuximab ฮฒ Combined With FOLFIRI as First-line /IBI351, Cetuximab ฮฒ as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
NCT06959589Colorectal Cancer Metastatic, KRAS G12C Mutation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
50
Hangzhou
2025-05-22
Recruiting
Comparison of Sequential to Initial Combination Therapy in PAH
NCT06968962Pulmonary Arterial Hypertension (PAH)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
376
Hangzhou
2025-05-14
Recruiting
Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
NCT06972576Non-Small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
18
Hangzhou
2025-05-09
Recruiting
Effect of Video Viewing on Intravitreal Injection Experience
NCT07002372Age Related Macular Degeneration, Diabetic Retinopathy, Choroidal Neovascularization, Retinal Vein Occlusion
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
182
Hangzhou
2025-05-05
Recruiting
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
NCT07078500Diffuse Large B-Cell Lymphoma (DLBCL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
48
Hangzhou
2025-05-05
Not yet open
Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study
NCT06924645Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting), Extrapulmonary Neuroendocrine Neoplasms
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2025-05-01
Recruiting
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
NCT06939712Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2025-05-01
Not yet open
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
NCT06960122Pancreatic Cancer, Resected, Diarrhea
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-05-01
Recruiting
Bevacizumab in the Treatment of HHT
NCT07828015Bevacizimab, HHT
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
40
Hangzhou
2025-05-01
Recruiting
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545Coronary Artery Disease, CT Angiography, PCSK9, Cardiovascular Events
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
3,596
Hangzhou, Jinhua
2025-04-22
Recruiting
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
NCT06902896Dilated Cardiomyopathy (DCM), Heart Failure
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hangzhou
2025-04-22
Recruiting
NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial
NCT07077551NENS
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
28
Hangzhou
2025-04-22
By invitation
VISOR Versus PCNL for Treatment of 2-4cm Renal Stones
NCT07159503Kidney Calculi, Kidney Stones
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
170
Hangzhou
2025-04-20
Recruiting
Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke
NCT06863571Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
68
Hangzhou
2025-04-12
Recruiting
Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors
NCT06952608Intraoperative Hypotension, Ciprofol, Renin-angiotensin System Inhibitors
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
140
Hangzhou
2025-04-10
Recruiting
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
NCT06946615Colorectal Neoplasia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
18
Hangzhou
2025-04-08
Active, closed
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
NCT06992024Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-04-01
Recruiting
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer
NCT06992648Colorectal Cancer Metastatic, Colorectal Cancer Recurrent
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
302
Hangzhou
2025-04-01
Recruiting
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
NCT07193654Glioblastoma (GBM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Hangzhou
2025-04-01
Recruiting
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
NCT06863532Type 2 Diabetes
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
80
Hangzhou
2025-03-30
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
51
Hangzhou, Dongyang, Huzhou, Jiaxing, Lishui, Ningbo, Quzhou, Shaoxing
2025-03-11
Recruiting
Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
NCT06964906ER+/HER2- Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2025-03-04
Active, closed
Blended Cardiac Rehabilitation Training for Cardiology Residents
NCT07755878Medical Education, Cardiac Rehabilitation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
98
Hangzhou
2025-03-03
Not yet open
The Use of Hydrogen Ion Water (Shan Shang Water) in the Treatment of Allergic Rhinitis
NCT06756243Allergic Rhinitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-03-01
Recruiting
Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
NCT06687408Lung Cancer, Non-Small Cell
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
450
Hangzhou, Shanghai
2025-03-01
Not yet open
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070Thrombosis, Acute Ischemic Stroke (AIS)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
390
Hangzhou
2025-03-01
Recruiting
Epidural Electrical Stimulation in Spinal Cord Injury
NCT07105878Spinal Cord Injuries (SCI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2025-03-01
By invitation
Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma
NCT06827782Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
42
Hangzhou
2025-03-01
Not yet open
A Single-blind, Randomized, Controlled Clinical Study of Flash Stimulation Therapy in Parkinson's Disease
NCT06848621Parkinson's Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
48
Hangzhou
2025-03-01
By invitation
Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions
NCT06816212Hepatic Malignant Tumors, Hepatic Perfusion Disorders
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
280
Hangzhou
2025-02-10
Recruiting
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
NCT07487480Inflamatory Bowel Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
60
Hangzhou
2025-02-10
Recruiting
SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
NCT06863584Solitary Plasmacytoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
41
Hangzhou
2025-02-10
Not yet open
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
NCT06766552Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Nr-axSpA, Polymyalgia Rheumatica (PMR)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
10,000
Hangzhou
2025-01-30
Recruiting
Intravenous Thrombolysis and NOAC
NCT06749834Acute Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
280
Hangzhou, Taizhou
2025-01-27
Recruiting
The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
NCT07381803Zhejiang University
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
2,804
Hangzhou
2025-01-27
Recruiting
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
NCT06548204ST-segment Elevation Myocardial Infarction (STEMI)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
160
Hangzhou
2025-01-20
Rows per page Showing 101–200 of 373
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 373 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

254 of the 373 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 68 have not yet opened recruitment, 38 are active but closed to new participants, and 13 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.